![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
RL Spencer, VJ Hruby and TF Burks
Department of Pharmacology, University of Arizona, Tucson.
In many cases, body temperature is altered in response to opioid agonists, but the direction, magnitude and time course of alteration vary with a number of factors. Body temperature may be subject to differential modification by different opioid receptor types. The authors examined the effect (i.c.v.) of the selective mu, delta and kappa opioid agonists, [D-Ala2, MePhe4, Gly5-ol] enkephalin (DAGO), [D- Pen2, D-Pen5] enkephalin and U50488H, respectively, on the body temperature of restrained and unrestrained rats. Each of the three opioid agonists produced a differentiable profile of body temperature changes. DAGO caused a primary decrease in body temperature of restrained rats and an increase in body temperature of unrestrained rats. The pretreatment dose of naloxone necessary to attenuate the hyperthermic response to DAGO of unrestrained rats was 10 times higher than that required to block the hypothermic response to DAGO in restrained rats. Low doses of both [D-Pen2, D-Pen5]enkephalin and U50488H caused a decrease in body temperature of both restrained and unrestrained rats. Hypothermic responses to U50488H were not blocked by naloxone, whereas hypothermic responses to [D-Pen2, D-Pen5]enkephalin in unrestrained rats were potentiated by naloxone. The results indicate that the three compounds modified body temperature by different means, suggesting activation of different opioid, and perhaps nonopioid, receptors. This may reflect a differential modulation of body temperature by endogenous opioids depending on the specific peptide released and the receptor type activated. Besides the physiologic implications, body temperature responses provided a sensitive pharmacologic measure for distinguishing the in vivo activity of different selective opioid agonists.
This article has been cited by other articles:
|
|
 |
|
  D. Fraga, R. R. Machado, L. C. Fernandes, G. E. P. Souza, and A. R. Zampronio Endogenous opioids: role in prostaglandin-dependent and -independent fever Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2008; 294(2): R411 - R420. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Benamar, M. Yondorf, V. T. Barreto, E. B. Geller, and M. W. Adler Deletion of {micro}-Opioid Receptor in Mice Alters the Development of Acute Neuroinflammation J. Pharmacol. Exp. Ther., December 1, 2007; 323(3): 990 - 994. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Y. Obese, B. K. Whitlock, B. P. Steele, F. C. Buonomo, and J. L. Sartin Long-term feed intake regulation in sheep is mediated by opioid receptors J Anim Sci, January 1, 2007; 85(1): 111 - 117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Ansonoff, J. Zhang, T. Czyzyk, R. B. Rothman, J. Stewart, H. Xu, J. Zjwiony, D. J. Siebert, F. Yang, B. L. Roth, et al. Antinociceptive and Hypothermic Effects of Salvinorin A Are Abolished in a Novel Strain of {kappa}-Opioid Receptor-1 Knockout Mice J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 641 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-H. Cao and S. F. Morrison Brown adipose tissue thermogenesis contributes to fentanyl-evoked hyperthermia Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2005; 288(3): R723 - R732. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Benamar, M. Z. Yondorf, D. Kon, E. B. Geller, and M. W. Adler Role of the Nitric-Oxide Synthase Isoforms during Morphine-Induced Hyperthermia in Rats J. Pharmacol. Exp. Ther., October 1, 2003; 307(1): 219 - 222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. P. Zuideveld, J. Rusic-Pavletic, H. J. Maas, L. A. Peletier, P. H. Van der Graaf, and M. Danhof Pharmacokinetic-Pharmacodynamic Modeling of Buspirone and Its Metabolite 1-(2-Pyrimidinyl)-piperazine in Rats J. Pharmacol. Exp. Ther., December 1, 2002; 303(3): 1130 - 1137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Benamar, E. B. Geller, and M. W. Adler Role of the Nitric Oxide Pathway in kappa -Opioid-Induced Hypothermia in Rats J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 375 - 378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Baker and T. F. Meert Functional Effects of Systemically Administered Agonists and Antagonists of {micro}, delta , and kappa Opioid Receptor Subtypes on Body Temperature in Mice J. Pharmacol. Exp. Ther., September 1, 2002; 302(3): 1253 - 1264. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Colman and J. H. Miller {micro}-1 Opioid Receptor Stimulation Decreases Body Temperature in Conscious, Unrestrained Neonatal Rats Experimental Biology and Medicine, June 1, 2002; 227(6): 377 - 381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Pohorecky, A. Skiandos, X. Zhang, K. C. Rice, and D. Benjamin Effect of Chronic Social Stress on delta -Opioid Receptor Function in the Rat J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 196 - 206. [Abstract] [Full Text]
|
|
|
|
|
|
S. B. Bausch, T. M. Esteb, G. W. Terman, and C. Chavkin Administered and Endogenously Released Kappa Opioids Decrease Pilocarpine-Induced Seizures and Seizure-Induced Histopathology J. Pharmacol. Exp. Ther., March 1, 1998; 284(3): 1147 - 1155. [Abstract] [Full Text]
|
|
|
|
|
|
L. Xin, E. B. Geller, and M. W. Adler Body Temperature and Analgesic Effects of Selective Mu and Kappa Opioid Receptor Agonists Microdialyzed into Rat Brain J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 499 - 507. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
